Eyeworld

by Title ASCRS NEWS Heading Name title Contact Name: email ASCRS ANNUAL MEETING PREVIEW 26 | EYEWORLD | SPRING 2025 A Q&A with the ASCRS Annual Meeting Program Chair Indication and Usage Qlosi TM is indicated for the treatment of presbyopia in adults. Important Safety Information Contraindications Hypersensitivity Warnings and Precautions Advise patients to not drive or operate machinery if vision is not clear (e.g., blurred vision). Exercise caution in night driving and other hazardous occupations in poor illumination. Rare cases of retinal detachment have been reported with miotics. Examination of the retina is advised in all patients prior to initiation of therapy. Advise patients to seek immediate medical care with sudden onset of flashes of lights, floaters, or vision loss. Qlosi TM is not recommended to be used when iritis is present. Qlosi TM should not be administered while wearing contact lenses. Remove lenses prior to the installation of Qlosi TM and wait 10 minutes before reinsertion. Avoid touching the tip of the vial to the eye or any other su-ace. Adverse Reactions The most common adverse reactions (5% to 8%) are instillation site pain and headaches. Please see full Prescribing Information here: www.qlosi.com/prescribing-information ©2025 Orasis Pharmaceuticals, Inc. All Rights Reserved. QLO. QLO.00117. A SCRS Annual Meeting Program Chair Thomas Samuelson, MD, spoke to EyeWorld about the upcoming Annual Meeting and what he's look- ing forward to. EyeWorld: Last year was your first year as ASCRS Annual Meeting Program Chair. How was the expe- rience? Dr. Samuelson: It has been a wonderful experience. I knew when I accepted the position that the program directors before me had left enormous shoes to fill. Accord- ingly, I tapped into the vast talent pool within the ASCRS leadership to help on the Main Stage. Nathan Radcliffe, MD, Sam Garg, MD, and Nicole Fram, MD, were outstand- ing as daily moderators last year. And of course, the ASCRS staff is extraordinary. I am amazed at how a small group of talented people skillfully pull together the vast, varied, and extensive content inherent to the Annual Meeting. EyeWorld: What are you looking forward to this year? Dr. Samuelson: Last year, we celebrated 50 years of ASCRS—a huge milestone. It was tremendously inspiring to review that early history. Likewise, this year will be very special for me because Richard Lindstrom, MD, my senior partner for 34 years and whose practice I joined right out of fellowship, is being inducted into the ASCRS Hall of Fame. An absolute titan in our field, Dr. Lindstrom has done so much for ASCRS and so much for me, both personally and professionally. It will be very special to have a front row seat and see him honored in this way by his ASCRS colleagues. EyeWorld: Why should people be sure to attend the 2025 ASCRS Annual Meeting? Dr. Samuelson: I think the ASCRS Annual Meeting pro- vides the most innovative, cutting-edge anterior segment curriculum available anywhere. I want to emphasize the "anterior segment" component of that comment. There are major distinctions among some fields within ophthalmol- ogy, like retina, pediatrics, and oculoplastics, for example. While those specialties remain mostly siloed and distinctly different from other areas in ophthalmology, the various anterior segment specialties, such as cornea, glaucoma, refractive, and cataract, have become increasingly inter- woven and synergistic. ASCRS is an unparalleled catalyst, bringing these anterior segment specialties together in one meeting.

• Cover